Background and study design Male breast cancer (MBC) is a rare disease compared with
female BC and our current understanding regarding breast carcinogenesis in men has been …

Male breast cancer is rare, accounting for 1% of all breast cancer diagnoses in the USA.
Because of its rarity, most major breast cancer trials have included only female patients. This …

Breast cancer is the most common cancer form in women and it has been extensively
studied on the molecular level. Male breast cancer (MBC), on the other hand, is rare and has …

Male breast cancer is a rare disease, accounting for only 1% of breast cancer diagnoses in
the USA. The current literature suggests that genetic factors including BRCA2 mutations …

Male breast cancer (MBC) is a poorly characterized disease because of its rarity. Clinical
management is based on results obtained from randomized trials conducted in women …

Purpose Because of its rarity, male breast cancer is often compared with female breast
cancer. Patients and Methods To compare and contrast male and female breast cancers, we …

Context.—The rate of male breast cancer is a small fraction of that observed in females, thus
severely limiting our understanding of the pathogenesis of this condition. It remains unclear …

Objective To comprehensively describe the tumor and clinical characteristics of breast
cancer in a cohort of male patients and to assess the factors that affect survival. Background …

Male breast cancer remains understudied despite evidence of rising incidence. Using a co-
ordinated multi-centre approach, we present the first large scale biomarker study to define …

In detection, treatment, and follow-up, male breast cancer has historically lagged behind
female breast cancer. On the whole, breast cancer is less common among men than among …